Acacia Research and Tectonic Therapeutic shares rise as analysts adjust ratings

Acacia Research Corp. (NASDAQ:ACTG) moved above its 200‑day moving average on Friday, trading as high as $4.55 and closing near $4.54 on about 293,000 shares exchanged. Weiss Ratings downgraded the stock to a sell, while one analyst maintained a buy stance. The company reported a quarterly loss of $0.07 per share, beating the consensus estimate, with revenue of $54.24 million, and saw several institutional investors add modest new positions.

Tectonic Therapeutic Inc. (NASDAQ:TECX) gained roughly 6 % mid‑day, reaching $32.40 and ending near $32.58 on lower-than‑average volume. Analyst opinions are mixed: Weiss kept a sell rating, Stifel issued a buy with a $75 target, Wall Street Zen shifted to strong sell, and Raymond James upgraded to strong buy with an $81 target. The firm posted a quarterly loss of $1.34 per share, missing analysts' expectations.